Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 73

1.

Serotonin transporter gene promoter methylation status correlates with in vivo prefrontal 5-HTT availability and reward function in human obesity.

Drabe M, Rullmann M, Luthardt J, Boettcher Y, Regenthal R, Ploetz T, Becker GA, Patt M, Schinke C, Bergh FT, Zientek F, Hilbert A, Bresch A, Fenske W, Hankir MK, Sabri O, Hesse S.

Transl Psychiatry. 2017 Jul 4;7(7):e1167. doi: 10.1038/tp.2017.133.

2.

BDNF val66met association with serotonin transporter binding in healthy humans.

Fisher PM, Ozenne B, Svarer C, Adamsen D, Lehel S, Baaré WF, Jensen PS, Knudsen GM.

Transl Psychiatry. 2017 Feb 14;7(2):e1029. doi: 10.1038/tp.2016.295.

3.

Attachment and Temperament Revisited: Infant Distress, Attachment Disorganization, and the Serotonin Transporter Polymorphism.

Brumariu LE, Bureau JF, Nemoda Z, Sasvari-Szekely M, Lyons-Ruth K.

J Reprod Infant Psychol. 2016;34(1):77-89. Epub 2015 Oct 6.

4.

Relationship of the serotonin transporter gene promoter polymorphism (5-HTTLPR) genotype and serotonin transporter binding to neural processing of negative emotional stimuli.

Schneck N, Miller JM, Delorenzo C, Kikuchi T, Sublette ME, Oquendo MA, Mann JJ, Parsey RV.

J Affect Disord. 2016 Jan 15;190:494-498. doi: 10.1016/j.jad.2015.10.047. Epub 2015 Nov 4.

5.

Positron emission tomography quantification of serotonin transporter binding in medication-free bipolar disorder.

Miller JM, Everett BA, Oquendo MA, Ogden RT, Mann JJ, Parsey RV.

Synapse. 2016 Jan;70(1):24-32. doi: 10.1002/syn.21868. Epub 2015 Oct 19.

6.

Affective neural responses modulated by serotonin transporter genotype in clinical anxiety and depression.

Oathes DJ, Hilt LM, Nitschke JB.

PLoS One. 2015 Feb 12;10(2):e0115820. doi: 10.1371/journal.pone.0115820. eCollection 2015.

7.

Disproportionate Reduction of Serotonin Transporter May Predict the Response and Adherence to Antidepressants in Patients with Major Depressive Disorder: A Positron Emission Tomography Study with 4-[18F]-ADAM.

Yeh YW, Ho PS, Kuo SC, Chen CY, Liang CS, Yen CH, Huang CC, Ma KH, Shiue CY, Huang WS, Shyu JF, Wan FJ, Lu RB, Huang SY.

Int J Neuropsychopharmacol. 2015 Jan 7;18(7):pyu120. doi: 10.1093/ijnp/pyu120.

8.

Positron emission tomography quantification of serotonin(1A) receptor binding in suicide attempters with major depressive disorder.

Sullivan GM, Oquendo MA, Milak M, Miller JM, Burke A, Ogden RT, Parsey RV, Mann JJ.

JAMA Psychiatry. 2015 Feb;72(2):169-78. doi: 10.1001/jamapsychiatry.2014.2406.

9.

The neurobiology of suicide - A Review of post-mortem studies.

Furczyk K, Schutová B, Michel TM, Thome J, Büttner A.

J Mol Psychiatry. 2013 Apr 23;1(1):2. doi: 10.1186/2049-9256-1-2. eCollection 2013. Review.

10.

Monoamine-sensitive developmental periods impacting adult emotional and cognitive behaviors.

Suri D, Teixeira CM, Cagliostro MK, Mahadevia D, Ansorge MS.

Neuropsychopharmacology. 2015 Jan;40(1):88-112. doi: 10.1038/npp.2014.231. Epub 2014 Sep 2. Review.

11.

Effects of genetic and early environmental risk factors for depression on serotonin transporter expression and methylation profiles.

Wankerl M, Miller R, Kirschbaum C, Hennig J, Stalder T, Alexander N.

Transl Psychiatry. 2014 Jun 17;4:e402. doi: 10.1038/tp.2014.37.

12.

The Genetics of Obsessive-Compulsive Disorder.

Bloch MH, Pittenger C.

Curr Psychiatry Rev. 2010 May 1;6(2):91-103.

13.

Human amygdala volume is predicted by common DNA variation in the stathmin and serotonin transporter genes.

Stjepanović D, Lorenzetti V, Yücel M, Hawi Z, Bellgrove MA.

Transl Psychiatry. 2013 Jul 16;3:e283. doi: 10.1038/tp.2013.41.

14.

Meta-analyses of the 5-HTTLPR polymorphisms and post-traumatic stress disorder.

Navarro-Mateu F, Escámez T, Koenen KC, Alonso J, Sánchez-Meca J.

PLoS One. 2013 Jun 25;8(6):e66227. doi: 10.1371/journal.pone.0066227. Print 2013.

15.

COMT Val158Met × SLC6A4 5-HTTLPR interaction impacts on gray matter volume of regions supporting emotion processing.

Radua J, El-Hage W, Monté GC, Gohier B, Tropeano M, Phillips ML, Surguladze SA.

Soc Cogn Affect Neurosci. 2014 Aug;9(8):1232-8. doi: 10.1093/scan/nst089. Epub 2013 Jun 6.

16.

Brain serotonin 1A receptor binding as a predictor of treatment outcome in major depressive disorder.

Miller JM, Hesselgrave N, Ogden RT, Zanderigo F, Oquendo MA, Mann JJ, Parsey RV.

Biol Psychiatry. 2013 Nov 15;74(10):760-7. doi: 10.1016/j.biopsych.2013.03.021. Epub 2013 May 9.

17.

Positron emission tomography quantification of serotonin transporter in suicide attempters with major depressive disorder.

Miller JM, Hesselgrave N, Ogden RT, Sullivan GM, Oquendo MA, Mann JJ, Parsey RV.

Biol Psychiatry. 2013 Aug 15;74(4):287-95. doi: 10.1016/j.biopsych.2013.01.024. Epub 2013 Mar 1.

18.

The serotonergic system in mood disorders and suicidal behaviour.

Mann JJ.

Philos Trans R Soc Lond B Biol Sci. 2013 Feb 25;368(1615):20120537. doi: 10.1098/rstb.2012.0537. Print 2013. Review.

19.

Serotonin transporter genotype affects serotonin 5-HT1A binding in primates.

Christian BT, Wooten DW, Hillmer AT, Tudorascu DL, Converse AK, Moore CF, Ahlers EO, Barnhart TE, Kalin NH, Barr CS, Schneider ML.

J Neurosci. 2013 Feb 6;33(6):2512-6. doi: 10.1523/JNEUROSCI.4182-12.2013.

20.

Serotonin transporter gene moderates associations between mood, memory and hippocampal volume.

Price JS, Strong J, Eliassen J, McQueeny T, Miller M, Padula CB, Shear P, Lisdahl K.

Behav Brain Res. 2013 Apr 1;242:158-65. doi: 10.1016/j.bbr.2012.11.013. Epub 2012 Dec 21.

Supplemental Content

Support Center